Arrowpoint Investment Partners (Singapore) Pte. Ltd.
13F Reported Value
ⓘ$112.5M
incl. option notional
Equity Holdings
ⓘ$68.8M
Option Notional
ⓘ$43.8M
$9.3M puts / $34.5M calls
Holdings
82
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Arrowpoint Investment Partners (Singapore) Pte. Ltd. disclosed 82 positions worth $112.5M in its Form 13F-HR for Q1 2026 — $68.8M in common stock plus $43.8M of put/call option positions (reported at underlying notional value, not premium at risk). During the quarter the fund opened 37 new positions and exited 53 and a full exit from $NVDA. The portfolio is most concentrated in Healthcare (69.3% of disclosed assets). All figures are sourced directly from Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s Form 13F-HR filing with the SEC under CIK 2032331.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
ISHARES TR CALL
—Quality
$18.5M230,800 shKRANESHARES TRUST CALL
—Quality
$11.4M400,000 sh- 80.2#45
Quality
$9.0M31,127 sh VANECK ETF TRUST PUT
—Quality
$8.4M22,000 shISHARES INC CALL
—Quality
$4.6M120,000 sh- —
Quality
$3.9M179,512 sh - 37.1
Quality
$2.9M38,988 sh - 75.4
Quality
$2.8M21,556 sh - 36.6
Quality
$2.8M16,401 sh - 74.1
Quality
$2.8M48,719 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| ISHARES TR CALL | — | $18.5M | 230,800 |
| KRANESHARES TRUST CALL | — | $11.4M | 400,000 |
 Alphabet Inc.$GOOG | 80.2#45 | $9.0M | 31,127 |
| VANECK ETF TRUST PUT | — | $8.4M | 22,000 |
| ISHARES INC CALL | — | $4.6M | 120,000 |
 ASE Technology Holding Co., Ltd.$ASX | — | $3.9M | 179,512 |
 IONIS PHARMACEUTICALS INC$IONS | 37.1 | $2.9M | 38,988 |
 NEUROCRINE BIOSCIENCES INC$NBIX | 75.4 | $2.8M | 21,556 |
 Axsome Therapeutics, Inc.$AXSM | 36.6 | $2.8M | 16,401 |
 BIOMARIN PHARMACEUTICAL INC$BMRN | 74.1 | $2.8M | 48,719 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s 82 positions.
Showing top 10 of 82 holdings.
Sector Allocation
Healthcare
$47.6M
Technology
$15.2M
Other
$4.9M
Financials
$899,256
Materials
$99,749
Real Estate
$28,997
Full Holdings — Arrowpoint Investment Partners (Singapore) Pte. Ltd. (Q1 2026)
All 82 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | ISHARES TR | $18.5M | — | NEW | — |
| 2 | — | KRANESHARES TRUST | $11.4M | — | NEW | — |
| 3 | $GOOG | Alphabet Inc. | $9.0M | 13.0% | +2123% | 80.2 |
| 4 | — | VANECK ETF TRUST | $8.4M | — | NEW | — |
| 5 | — | ISHARES INC | $4.6M | — | NEW | — |
| 6 | $ASX | ASE Technology Holding Co., Ltd. | $3.9M | 5.7% | NEW | — |
| 7 | $IONS | IONIS PHARMACEUTICALS INC | $2.9M | 4.3% | +56% | 37.1 |
| 8 | $NBIX | NEUROCRINE BIOSCIENCES INC | $2.8M | 4.1% | +513% | 75.4 |
| 9 | $AXSM | Axsome Therapeutics, Inc. | $2.8M | 4.0% | +677% | 36.6 |
| 10 | $BMRN | BIOMARIN PHARMACEUTICAL INC | $2.8M | 4.0% | NEW | 74.1 |
| 11 |  $ASND | Ascendis Pharma A/S | $2.7M | 3.9% | +295% | 41.5 |
| 12 |  $PTCT | PTC THERAPEUTICS, INC. | $2.7M | 3.9% | +330% | 80 |
| 13 |  $PFE | PFIZER INC | $2.0M | 2.9% | +65% | 69 |
| 14 |  $REGN | REGENERON PHARMACEUTICALS, INC. | $1.9M | 2.8% | +63% | 75.1 |
| 15 |  $JNJ | JOHNSON & JOHNSON | $1.9M | 2.8% | -97% | 72.8 |
| 16 |  $AMGN | AMGEN INC | $1.7M | 2.5% | -17% | 79.5 |
| 17 |  $GILD | GILEAD SCIENCES, INC. | $1.7M | 2.4% | -38% | 77.8 |
| 18 |  $VRTX | VERTEX PHARMACEUTICALS INC / MA | $1.5M | 2.2% | +1% | 76.6 |
| 19 |  $MCHP | MICROCHIP TECHNOLOGY INC | $1.5M | 2.2% | NEW | 40 |
| 20 |  $UNH | UNITEDHEALTH GROUP INC | $1.4M | 2.0% | NEW | 66.8 |
| 21 |  $PRAX | Praxis Precision Medicines, Inc. | $1.2M | 1.8% | +85% | — |
| 22 |  $INSM | INSMED Inc | $1.1M | 1.7% | -39% | 29.4 |
| 23 |  $PTGX | Protagonist Therapeutics, Inc | $983,804 | 1.4% | NEW | 24.8 |
| 24 |  $BLTE | BELITE BIO, INC | $957,278 | 1.4% | +97% | — |
| 25 | — | ISHARES INC | $886,500 | 1.3% | NEW | — |
| 26 |  $MRNA | Moderna, Inc. | $868,528 | 1.3% | NEW | 15.9 |
| 27 | — | ISHARES TR | $867,353 | — | NEW | — |
| 28 |  $BIIB | BIOGEN INC. | $862,751 | 1.3% | +65% | 65.6 |
| 29 |  $TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $777,247 | 1.1% | -83% | — |
| 30 |  $RVMD | Revolution Medicines, Inc. | $775,180 | 1.1% | +149% | — |
| 31 | — | SELECT SECTOR SPDR TR | $752,596 | 1.1% | -68% | — |
| 32 |  $OSG | OCTAVE SPECIALTY GROUP INC | $647,131 | 0.9% | -31% | 39 |
| 33 |  $TWST | Twist Bioscience Corp | $640,380 | 0.9% | +35% | 33.3 |
| 34 |  $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $623,976 | 0.9% | +221% | 25.4 |
| 35 | — | ISHARES TR | $615,499 | 0.9% | +610% | — |
| 36 |  $BNTX | BioNTech SE | $612,383 | 0.9% | NEW | — |
| 37 |  $NTRA | Natera, Inc. | $593,970 | 0.9% | NEW | 46.4 |
| 38 |  $AXGN | Axogen, Inc. | $539,124 | 0.8% | -15% | 38 |
| 39 | — | SELECT SECTOR SPDR TR | $533,709 | 0.8% | +18% | — |
| 40 |  $COGT | Cogent Biosciences, Inc. | $530,546 | 0.8% | +87% | — |
| 41 | — | SELECT SECTOR SPDR TR | $520,710 | 0.8% | +372% | — |
| 42 | — | SELECT SECTOR SPDR TR | $516,474 | 0.8% | +425% | — |
| 43 |  $CYTK | CYTOKINETICS INC | $486,943 | 0.7% | +65% | 28 |
| 44 |  $GMAB | GENMAB A/S | $430,085 | 0.6% | -63% | — |
| 45 |  $BBIO | BridgeBio Pharma, Inc. | $429,594 | 0.6% | +98% | 31.7 |
| 46 |  $TNGX | Tango Therapeutics, Inc. | $428,086 | 0.6% | NEW | 26.9 |
| 47 |  $COO | COOPER COMPANIES, INC. | $421,564 | 0.6% | -43% | 55.8 |
| 48 |  $LLY | ELI LILLY & Co | $406,538 | 0.6% | -95% | 89.3 |
| 49 |  $ERAS | Erasca, Inc. | $402,024 | 0.6% | NEW | — |
| 50 |  $LITE | Lumentum Holdings Inc. | $394,951 | 0.6% | -95% | 63.4 |
| 51 |  $ILMN | ILLUMINA, INC. | $372,985 | 0.5% | NEW | 62.5 |
| 52 |  $BIOA | BioAge Labs, Inc. | $363,722 | 0.5% | NEW | 28.6 |
| 53 |  $APGE | Apogee Therapeutics, Inc. | $337,269 | 0.5% | -37% | — |
| 54 |  $IBRX | ImmunityBio, Inc. | $314,508 | 0.5% | NEW | 30 |
| 55 |  $UTHR | UNITED THERAPEUTICS Corp | $312,500 | 0.5% | NEW | 80.1 |
| 56 |  $DYN | Dyne Therapeutics, Inc. | $312,072 | 0.5% | +20% | — |
| 57 |  $SYRE | Spyre Therapeutics, Inc. | $309,702 | 0.5% | -55% | — |
| 58 |  $TYRA | Tyra Biosciences, Inc. | $309,273 | 0.5% | NEW | — |
| 59 | — | SELECT SECTOR SPDR TR | $306,094 | 0.5% | -74% | — |
| 60 |  $SPY | SPDR S&P 500 ETF TRUST | $273,143 | 0.4% | NEW | — |
| 61 |  $ALMS | ALUMIS INC. | $265,043 | 0.4% | NEW | 9.2 |
| 62 |  $ORKA | Oruka Therapeutics, Inc. | $252,460 | 0.4% | NEW | — |
| 63 |  $EQH | Equitable Holdings, Inc. | $252,125 | 0.4% | NEW | 48.9 |
| 64 | — | FRANKLIN TEMPLETON ETF TR | $252,007 | 0.4% | NEW | — |
| 65 |  $SMMT | Summit Therapeutics Inc. | $230,099 | 0.3% | NEW | — |
| 66 |  $NVST | Envista Holdings Corp | $228,355 | 0.3% | -39% | 49.8 |
| 67 |  $CGON | CG Oncology, Inc. | $228,082 | 0.3% | NEW | 28 |
| 68 |  $DXCM | DEXCOM INC | $227,838 | 0.3% | NEW | 77.9 |
| 69 |  $NKTR | NEKTAR THERAPEUTICS | $203,619 | 0.3% | -43% | 10.2 |
| 70 |  $GPCR | Structure Therapeutics Inc. | $201,958 | 0.3% | NEW | — |
| 71 |  $VSTM | Verastem, Inc. | $191,701 | 0.3% | NEW | 40.8 |
| 72 | — | VANECK ETF TRUST | $183,540 | 0.3% | -68% | — |
| 73 |  $CLYM | Climb Bio, Inc. | $168,442 | 0.2% | NEW | — |
| 74 |  $UAMY | UNITED STATES ANTIMONY CORP | $99,749 | 0.1% | NEW | 32.2 |
| 75 |  $GOOGL | Alphabet Inc. | $86,058 | 0.1% | +50% | 80.2 |
| 76 |  $IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $69,358 | 0.1% | NEW | 30.6 |
| 77 |  $NMRA | Neumora Therapeutics, Inc. | $31,200 | 0.1% | NEW | — |
| 78 |  $BDN | BRANDYWINE REALTY TRUST | $28,997 | 0.0% | NEW | 31.5 |
| 79 | — | SELECT SECTOR SPDR TR | $26,580 | 0.0% | -98% | — |
| 80 |  $PLUG | PLUG POWER INC | $25,330 | 0.0% | NEW | 18.8 |
| 81 | — | ISHARES TR | $23,420 | 0.0% | +0% | — |
| 82 | — | KRANESHARES TRUST | $11,372 | 0.0% | -99% | — |
New Positions (37)
$ASX ASE Technology Holding Co., Ltd.$3.9M$BMRN BIOMARIN PHARMACEUTICAL INC$2.8M$MCHP MICROCHIP TECHNOLOGY INC$1.5M$UNH UNITEDHEALTH GROUP INC$1.4M$PTGX Protagonist Therapeutics, Inc$983,804$MRNA Moderna, Inc.$868,528$BNTX BioNTech SE$612,383$NTRA Natera, Inc.$593,970$TNGX Tango Therapeutics, Inc.$428,086Exited Positions (53)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Arrowpoint Investment Partners (Singapore) Pte. Ltd. including:
Track Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Arrowpoint Investment Partners (Singapore) Pte. Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Arrowpoint Investment Partners (Singapore) Pte. Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Arrowpoint Investment Partners (Singapore) Pte. Ltd. (SEC CIK: 2032331), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.